DJIA 17,826.30 -279.47 -1.54%
NASDAQ 4,931.82 -75.98 -1.52%
S&P 500 2,081.18 -23.81 -1.13%
market minute promo

42.49 -1.12 (-2.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NBIX $42.49 -2.57%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.13
Previous Close $43.61
Daily Range $41.07 - $43.43
52-Week Range $12.63 - $45.36
Market Cap $3.3B
P/E Ratio -53.84
Dividend (Yield) $0.00 (0.0%)
Volume 943,176
Average Daily Volume 1,022,900
Current FY EPS -$1.13

Sector

Healthcare

Industry

Drug Makers

Neurocrine Biosciences, Inc. (NBIX) Description

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/

News & Commentary

NBIX's Top Competitors

NBIX $42.49 (-2.57%)
Current stock: NBIX
BIIB $419.44 (-2.15%)
Current stock: BIIB
AMGN $163.58 (-1.97%)
Current stock: AMGN
CELG $113.47 (-2.48%)
Current stock: CELG